Related Experiment Video
Updated: Nov 10, 2025

Transverse Aortic Constriction in Mice
Published on: April 21, 2010
Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1s/sα2s/s Mouse Model of High Affinity
Pauline V Marck1, Marco T Pessoa1, Yunhui Xu1
1Marshall Institute for Interdisciplinary Research, Huntington, WV 25703, USA.
Abstract:
The Na/K-ATPase is the specific receptor for cardiotonic steroids (CTS) such as ouabain and digoxin. At pharmacological concentrations used in the treatment of cardiac conditions, CTS inhibit the ion-pumping function of Na/K-ATPase. At much lower concentrations, in the range of those reported for endogenous CTS in the blood, they stimulate hypertrophic growth of cultured cardiac myocytes through initiation of a Na/K-ATPase-mediated and reactive oxygen species (ROS)-dependent signaling. To examine a possible effect of endogenous concentrations of CTS on cardiac structure and function in vivo, we compared mice expressing the naturally resistant Na/K-ATPase α1 and age-matched mice genetically engineered to express a mutated Na/K-ATPase α1 with high affinity for CTS. In this model, total cardiac Na/K-ATPase activity, α1, α2, and β1 protein content remained unchanged, and the cardiac Na/K-ATPase dose-response curve to ouabain shifted to the left as expected. In males aged 3-6 months, increased α1 sensitivity to CTS resulted in a significant increase in cardiac carbonylated protein content, suggesting that ROS production was elevated. A moderate but significant increase of about 15% of the heart-weight-to-tibia-length ratio accompanied by an increase in the myocyte cross-sectional area was detected. Echocardiographic analyses did not reveal any change in cardiac function, and there was no fibrosis or re-expression of the fetal gene program. RNA sequencing analysis indicated that pathways related to energy metabolism were upregulated, while those related to extracellular matrix organization were downregulated. Consistent with a functional role of the latter, an angiotensin-II challenge that triggered fibrosis in the α1r/rα2s/s mouse failed to do so in the α1s/sα2s/s. Taken together, these results are indicative of a link between circulating CTS, Na/K-ATPase α1, ROS, and physiological cardiac hypertrophy in mice under baseline laboratory conditions.
Insights
Endogenous cardiotonic steroids (CTS) stimulate physiological cardiac hypertrophy in mice by increasing Na/K-ATPase α1 sensitivity, leading to elevated reactive oxygen species (ROS) and altered gene expression without impairing cardiac function.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Endocrinology
Background:
- Cardiotonic steroids (CTS) like ouabain and digoxin interact with Na/K-ATPase.
- Pharmacological CTS concentrations inhibit Na/K-ATPase, while endogenous levels may stimulate cardiac myocyte growth via Na/K-ATPase and ROS signaling.
Purpose of the Study:
- To investigate the in vivo effects of endogenous CTS concentrations on cardiac structure and function.
- To explore the role of Na/K-ATPase α1 affinity for CTS in physiological cardiac hypertrophy.
Main Methods:
- Comparison of mice with naturally resistant Na/K-ATPase α1 versus those engineered for high CTS affinity.
- Analysis of cardiac protein content, Na/K-ATPase activity, ROS markers (carbonylated protein), cardiac structure (heart-weight-to-tibia-length ratio, myocyte size), cardiac function (echocardiography), gene expression (RNA sequencing), and fibrosis response to angiotensin-II challenge.
Main Results:
- Increased Na/K-ATPase α1 sensitivity to CTS elevated cardiac ROS production and myocyte size.
- A significant increase in heart-weight-to-tibia-length ratio was observed.
- No changes in cardiac function, fibrosis, or fetal gene program re-expression were detected.
- RNA sequencing revealed upregulated energy metabolism pathways and downregulated extracellular matrix organization pathways.
Conclusions:
- Circulating CTS, Na/K-ATPase α1, and ROS are linked to physiological cardiac hypertrophy in mice.
- Enhanced CTS sensitivity of Na/K-ATPase α1 promotes adaptive cardiac remodeling.
- The findings suggest a novel mechanism for regulating cardiac mass under physiological conditions.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure II: Pathophysiology
Pathophysiology of Cardiac Performance

